• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bone marrow-derived fibrocytes contribute to liver fibrosis.骨髓来源的纤维细胞促成肝纤维化。
Exp Biol Med (Maywood). 2015 Jun;240(6):691-700. doi: 10.1177/1535370215584933. Epub 2015 May 12.
2
Contribution of bone marrow-derived fibrocytes to liver fibrosis.骨髓源性成纤维细胞在肝纤维化中的作用。
Hepatobiliary Surg Nutr. 2015 Feb;4(1):34-47. doi: 10.3978/j.issn.2304-3881.2015.01.01.
3
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.骨髓来源的纤维细胞参与肝纤维化的发病机制。
J Hepatol. 2006 Sep;45(3):429-38. doi: 10.1016/j.jhep.2006.04.014. Epub 2006 Jun 9.
4
Migration of fibrocytes in fibrogenic liver injury.成纤维细胞在肝纤维化损伤中的迁移。
Am J Pathol. 2011 Jul;179(1):189-98. doi: 10.1016/j.ajpath.2011.03.049. Epub 2011 May 19.
5
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis.骨髓源性干细胞在肝纤维化中的表型命运和功能作用。
J Hepatol. 2012 Apr;56(4):965-72. doi: 10.1016/j.jhep.2011.09.021. Epub 2011 Dec 13.
6
Bone marrow-derived cells contribute to cerulein-induced pancreatic fibrosis in the mouse.骨髓来源的细胞有助于在小鼠的雨蛙肽诱导的胰腺纤维化。
Int J Exp Pathol. 2012 Apr;93(2):130-8. doi: 10.1111/j.1365-2613.2011.00804.x. Epub 2012 Jan 27.
7
Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.骨髓移植显示 CD34+纤维细胞的骨髓起源,并改善 Abcb4-/- 小鼠的肝纤维化。
Hepatology. 2010 Jan;51(1):267-76. doi: 10.1002/hep.23274.
8
The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.肝纤维化中活化的肝门成纤维细胞/肌成纤维细胞的特征
Differentiation. 2016 Sep;92(3):84-92. doi: 10.1016/j.diff.2016.07.001. Epub 2016 Aug 31.
9
Fibrocytes, Wound Healing, and Corneal Fibrosis.成纤维细胞、伤口愈合和角膜纤维化。
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):28. doi: 10.1167/iovs.61.2.28.
10
Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?改变肝纤维化的发病机制路径?它从何开始,又将走向何方?
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1024-35. doi: 10.1111/j.1440-1746.2008.05345.x. Epub 2008 May 26.

引用本文的文献

1
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
2
A Rare Skeletal Disorder, Fibrous Dysplasia: A Review of Its Pathogenesis and Therapeutic Prospects.一种罕见的骨骼疾病,纤维结构不良:发病机制和治疗前景的综述。
Int J Mol Sci. 2023 Oct 26;24(21):15591. doi: 10.3390/ijms242115591.
3
Mechanisms of liver fibrosis in metabolic syndrome.代谢综合征中的肝纤维化机制。
eGastroenterology. 2023 Jun;1(1). doi: 10.1136/egastro-2023-100015.
4
HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors.HDAC9 作为一个特权靶点:综述其在不同疾病中的作用及其抑制剂的构效关系(SARs)。
Mini Rev Med Chem. 2024;24(7):767-784. doi: 10.2174/0113895575267301230919165827.
5
Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis.肝星状细胞的单细胞转录组学揭示了非酒精性脂肪性肝炎中涉及的关键途径和关键调节因子。
Endocr Connect. 2023 Jan 18;12(2). doi: 10.1530/EC-22-0502. Print 2023 Feb 1.
6
NOX as a Therapeutic Target in Liver Disease.NOX作为肝脏疾病的治疗靶点
Antioxidants (Basel). 2022 Oct 16;11(10):2038. doi: 10.3390/antiox11102038.
7
Computational simulation of liver fibrosis dynamics.肝纤维化动力学的计算模拟。
Sci Rep. 2022 Aug 18;12(1):14112. doi: 10.1038/s41598-022-18123-w.
8
Novel Usefulness of Krebs von den Lungen 6 (KL-6) with Hemoglobin and Lactate Dehydrogenase for Assessing Bone Marrow Fibrosis.克雷布斯-冯-登-伦根6(KL-6)联合血红蛋白和乳酸脱氢酶在评估骨髓纤维化中的新用途。
Diagnostics (Basel). 2022 Mar 3;12(3):628. doi: 10.3390/diagnostics12030628.
9
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future.2022 年肝脏纤维化:未满足的需求和未来蓝图。
Hepatology. 2022 Feb;75(2):473-488. doi: 10.1002/hep.32285. Epub 2022 Jan 11.
10
Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.STAT6 的药理学抑制可改善肾纤维化中髓系成纤维细胞的激活和替代性巨噬细胞的极化。
Front Immunol. 2021 Aug 26;12:735014. doi: 10.3389/fimmu.2021.735014. eCollection 2021.

本文引用的文献

1
Origin of myofibroblasts in the fibrotic liver in mice.小鼠肝纤维化中肌成纤维细胞的起源。
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3297-305. doi: 10.1073/pnas.1400062111. Epub 2014 Jul 29.
2
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.命运追踪揭示了肝星状细胞是肝纤维化的主要贡献者,而与病因无关。
Nat Commun. 2013;4:2823. doi: 10.1038/ncomms3823.
3
Inactivation of myofibroblasts during regression of liver fibrosis.肝纤维化消退过程中肌成纤维细胞的失活
Cell Cycle. 2013 Feb 1;12(3):381-2. doi: 10.4161/cc.23549. Epub 2013 Jan 16.
4
Isolation of rat portal fibroblasts by in situ liver perfusion.通过原位肝脏灌注分离大鼠门静脉成纤维细胞。
J Vis Exp. 2012 Jun 29(64):3669. doi: 10.3791/3669.
5
Mechanisms of fibrosis: therapeutic translation for fibrotic disease.纤维化机制:纤维化疾病的治疗转化。
Nat Med. 2012 Jul 6;18(7):1028-40. doi: 10.1038/nm.2807.
6
Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.在小鼠肝纤维化消退过程中肝星状细胞的失活。
Gastroenterology. 2012 Oct;143(4):1073-83.e22. doi: 10.1053/j.gastro.2012.06.036. Epub 2012 Jun 27.
7
Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.细胞色素 P450 2E1(CYP2E1)在高脂肪诱导的非酒精性脂肪性肝炎发展中的关键作用。
J Hepatol. 2012 Oct;57(4):860-6. doi: 10.1016/j.jhep.2012.05.019. Epub 2012 Jun 2.
8
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.肌成纤维细胞在肝纤维化消退过程中会恢复为非激活表型。
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9448-53. doi: 10.1073/pnas.1201840109. Epub 2012 May 7.
9
Mouse intragastric infusion (iG) model.小鼠灌胃(iG)模型。
Nat Protoc. 2012 Mar 29;7(4):771-81. doi: 10.1038/nprot.2012.014.
10
Morphogens and hepatic stellate cell fate regulation in chronic liver disease.形态发生素与慢性肝病中肝星状细胞命运调控。
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2(Suppl 2):94-8. doi: 10.1111/j.1440-1746.2011.07022.x.

骨髓来源的纤维细胞促成肝纤维化。

Bone marrow-derived fibrocytes contribute to liver fibrosis.

作者信息

Xu Jun, Kisseleva Tatiana

机构信息

Department of Medicine, University of California, San Diego, CA 92093, USA.

Department of Surgery, University of California, San Diego, CA 92093, USA

出版信息

Exp Biol Med (Maywood). 2015 Jun;240(6):691-700. doi: 10.1177/1535370215584933. Epub 2015 May 12.

DOI:10.1177/1535370215584933
PMID:25966982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4866973/
Abstract

Chronic liver injury often leads to hepatic fibrosis, a condition associated with increased levels of circulating TGF-β1 and lipopolysaccharide, activation of myofibroblasts, and extensive deposition of extracellular matrix, mostly collagen Type I. Hepatic stellate cells are considered to be the major(1) but not the only source of myofibroblasts in the injured liver.(2) Hepatic myofibroblasts may also originate from portal fibroblasts, mesenchymal cells, and fibrocytes.(3) Since the discovery of fibrocytes in 1994 by Dr. Bucala and colleagues, this bone marrow (BM)-derived collagen Type I-producing CD45(+) cells remain the most fascinating cells of the hematopoietic system. Due to the ability to differentiate into collagen Type I producing cells/myofibroblasts, fibrocytes were implicated in the pathogenesis of liver, skin, lung, and kidney fibrosis. However, studies of different organs often contain controversial results on the number of fibrocytes recruited to the site of injury and their biological function. Furthermore, fibrocytes were implicated in the pathogenesis of sepsis and were shown to possess antimicrobial activity. Finally, in response to specific stimuli, fibrocytes can give rise to fully differentiated macrophages, suggesting that in concurrence with the high plasticity of hematopoietic cells, fibrocytes exhibit progenitor properties. Here, we summarize our current understanding of the role of CD45(+)Collagen Type I(+) BM-derived cells in response to fibrogenic liver injury and septicemia and discuss the most recent evidence supporting the critical role of fibrocytes in the mediation of pro-fibrogenic and/or pro-inflammatory responses.

摘要

慢性肝损伤常导致肝纤维化,这种病症与循环中转化生长因子-β1和脂多糖水平升高、肌成纤维细胞活化以及细胞外基质(主要是I型胶原)的大量沉积有关。肝星状细胞被认为是受损肝脏中肌成纤维细胞的主要(1)但并非唯一来源。(2)肝肌成纤维细胞也可能源自门周成纤维细胞、间充质细胞和纤维细胞。(3)自1994年布卡拉博士及其同事发现纤维细胞以来,这种源自骨髓(BM)的产生I型胶原的CD45(+)细胞一直是造血系统中最引人关注的细胞。由于能够分化为产生I型胶原的细胞/肌成纤维细胞,纤维细胞被认为与肝、皮肤、肺和肾纤维化的发病机制有关。然而,针对不同器官的研究,在损伤部位募集的纤维细胞数量及其生物学功能方面,往往得出相互矛盾的结果。此外,纤维细胞还被认为与脓毒症的发病机制有关,并被证明具有抗菌活性。最后,在特定刺激下,纤维细胞可分化为完全成熟的巨噬细胞,这表明纤维细胞与造血细胞的高可塑性一致,具有祖细胞特性。在此,我们总结了目前对源自骨髓的CD45(+)I型胶原(+)细胞在应对致纤维化肝损伤和败血症时所起作用的理解,并讨论了支持纤维细胞在介导促纤维化和/或促炎反应中起关键作用的最新证据。